Skye Bioscience, Inc.SKYENASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+91.7%
5Y CAGR+85.2%
Year-over-Year Change
Research and development spending
3Y CAGR
+91.7%/yr
vs +106.6%/yr prior
5Y CAGR
+85.2%/yr
Recent acceleration
Acceleration
-14.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
21.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $42.36M | +126.5% |
| 2024 | $18.70M | +221.4% |
| 2023 | $5.82M | -3.2% |
| 2022 | $6.01M | +105.1% |
| 2021 | $2.93M | +50.8% |
| 2020 | $1.94M | -13.1% |
| 2019 | $2.24M | +577.6% |
| 2018 | $329966.00 | +6.0% |
| 2017 | $311302.00 | -66.8% |
| 2016 | $939040.00 | - |